低危胸痛患者运动负荷试验与负荷心肌灌注显像的成本效益比较
该研究比较了在临床决策单元观察的低危胸痛患者接受运动平板试验与负荷心肌灌注显像的主要不良心脏事件、下游资源利用和直接成本。倾向性评分匹配后共680例患者(340对),两组主要不良心脏事件率无差异,负荷心肌灌注显像组重复检查更少但直接成本更高、住院时间更长。
要点
- 低危胸痛患者中运动平板试验与负荷心肌灌注显像的主要不良心脏事件率无差异
- 负荷心肌灌注显像组直接成本较运动平板试验组高30%(3168.70美元 vs 2226.96美元)
- 负荷心肌灌注显像组超过24小时出院的患者数是运动平板试验组的两倍
核心结论
- 低危胸痛观察单元患者的主要不良心脏事件率低,运动平板试验与负荷心肌灌注显像之间无差异。
- 大多数运动平板试验和负荷心肌灌注显像结果正常。
- 负荷心肌灌注显像减少了额外检查,但导致费用更高和住院时间更长。
研究设计与样本
- 来自2个中心的1016名受试者按年龄、性别、验前概率、Duke平板评分和检查结果进行倾向性评分匹配。
- 倾向性评分匹配后得到680例患者(340对匹配)。
- 结局包括住院时间超过24小时、主要不良心脏事件(急性冠脉综合征、血运重建、心源性死亡)、下游资源使用(因胸痛入院、重复检查、血管造影)和每例患者平均直接成本。
主要发现
- 所有检查中98%为正常。
- 96.6%的患者在24小时内从临床决策单元出院,但负荷心肌灌注显像组超过24小时出院的人数是运动平板试验组的两倍。
- 无心脏死亡;主要不良心脏事件率在72小时为1.47%,在1年为1%。
- 下游资源使用在72小时为4.82%,在1年为7.69%。
- 负荷心肌灌注显像组无事件时间更长,反映重复检查更少;平均直接成本负荷心肌灌注显像组为3168.70美元,运动平板试验组为2226.96美元,负荷心肌灌注显像组高30%。
关键数值与推荐
- 主要不良心脏事件率在72小时为1.47%,在1年为1%。
- 下游资源使用在72小时为4.82%,在1年为7.69%。
- 平均直接成本负荷心肌灌注显像组为3168.70美元,运动平板试验组为2226.96美元,负荷心肌灌注显像组高30%。
- 96.6%的患者在24小时内从临床决策单元出院,负荷心肌灌注显像组超过24小时出院的人数是运动平板试验组的两倍。
临床怎么用
- 低危胸痛患者在观察单元中主要不良心脏事件率低,运动平板试验与负荷心肌灌注显像之间无差异。
- 负荷心肌灌注显像减少了额外检查,但费用更高且住院时间更长。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare major adverse cardiac event (MACE), downstream resource utilization, and direct cost of care for low-risk chest pain patients observed in the clinical decision unit (CDU) with exercise treadmill testing (ETT) and with stress-only myocardial perfusion imaging (sMPI). BACKGROUND: CDUs are poised to increase efficiency and resource utilization. However, the optimal testing strategy that would assure favorable outcomes while decreasing cost is not defined. METHODS: 1016 subjects from 2 locations were propensity score-matched (PSM) by age, gender, pre-test likelihood, Duke treadmill score, and test results. Outcomes were length of stay >24 hours, MACE (acute coronary syndrome, revascularization, cardiac death), downstream resource use (admission for chest pain, repeat testing, angiography), and mean direct cost per patient. RESULTS: PSM yielded 680 patients (340 matches). 98% of all tests were normal. 96.6% of patients were discharged from the CDU within 24 hours but twice as many exceeded 24 hours in the sMPI group. There were no cardiac deaths. MACE rate was 1.47% at 72 hours and 1% at 1 year. Downstream resource use was 4.82% at 72 hours, and 7.69% at 1 year. The sMPI group was event-free longer than the ETT group reflecting less repeat testing. The mean direct cost was 30% higher for sMPI ($3168.70) vs. ETT ($2226.96). CONCLUSION: Low-risk chest pain patients in the observation unit had low MACE rate, not different for ETT vs. sMPI. The majority of ETT and sMPI tests were normal. The sMPI reduced additional testing, but resulted in greater expense and longer stay.
引用
- Amirian J, Javdan O, Misher J, et al. Comparative efficiency of exercise stress testing with and without stress-only myocardial perfusion imaging in patients with low-risk chest pain. J Nucl Cardiol. 2017. PMID: 28083830. doi:10.1007/s12350-016-0774-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。